Indication: Treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history, or
presence of, tophus and/or gouty arthritis).
Contraindication: Hypersensitivity to Febuxostat (Feburic®,) or to any of the excipients listed in List of excipients

Place of Origin

Patheon, France

Directions

The recommended oral dose of Febuxostat (Feburic®,) is 80 mg once daily without regard to food. If serum uric acid is >, 6 mg/dL (357 &mu,mol/L) after 2-4 weeks, the dose of 120 mg once daily may be considered.
Febuxostat (Feburic®,) works sufficiently quickly to allow retesting of the serum uric acid after 2 weeks. The therapeutic target is to decrease and maintain serum uric acid below 6 mg/dL (357 &mu,mol/L).
Gout flare prophylaxis of at least 6 months is recommended

Ingredients

List of excipients
Tablet core

Warnings

Not recommended use in patients w/ ischaemic heart disease or CHF &